PrEP
NCCN Guidelines Recommend mAbs for COVID-19 PrEP in People With Cancer
NCCN Guidelines for the Prevention and Treatment of Cancer-Related Infections advise clinicians recommend mAbs to ...
AUGUST 5, 2025
Data Shows Preference for CAB-LA PrEP Without Straining Clinics
Two studies presented at IAS 2025 demonstrated the acceptability and feasibility of using Apretude for PrEP in ...
JULY 22, 2025
Key Takeaways for PrEP, HIV Treatment and Other Infectious Diseases
CROI 2025 highlighted promising therapeutic modalities for HIV treatment and prevention.
JULY 9, 2025
FDA Approves Yeztugo for HIV PrEP Lasting 6 Months
The FDA approved lenacapavir, an injectable HIV-1 capsid inhibitor, to be used as PrEP to reduce the risk of ...
JUNE 18, 2025
Collaborative Practice Agreement Reduces Time to PrEP Access
Adding a collaborative practice agreement with pharmacists significantly accelerated initiation of long-acting, ...
DECEMBER 16, 2024
One-Fourth of Initial PrEP Prescriptions Not Dispensed
Approximately 1 in 4 first prescriptions for oral pre-exposure prophylaxis for HIV prevention are not dispensed ...
DECEMBER 16, 2024
Twice-Yearly Lenacapavir 100% Effective in Preventing HIV Among Cisgender Women
An interim analysis of PURPOSE 1 found twice-yearly lenacapavir was superior to once-daily oral FTC/TDF in ...
JULY 24, 2024
Overcoming the Challenges of Adhering to Injectable ART and PrEP
Before 2021, oral medication was the only option for HIV prevention and treatment, but adherence has always been a ...
JUNE 27, 2024
New Fellowship to Improve HIV Prevention in Key Communities Available
A new fellowship—The Dr. Dawn K. Smith HIV Prevention Clinical Fellowship—to provide comprehensive HIV ...
MARCH 18, 2024
USPSTF Gives ‘A’ Rating to All 3 Approved PrEP Medications, but Access Challenges Remain
In addition to Truvada, the new recommendations also include the daily oral drug Descovy and the long-acting ...
SEPTEMBER 6, 2023
Sometimes Even ‘Detectable’ Can Mean Untransmissible
People living with HIV who maintain low—but still detectible—levels of the virus but adhere to their ...
JULY 26, 2023
Fast-Dissolving Suppository Shows Promise for Preventing HIV From Anal Sex
A fast-dissolving suppository being developed as an “on-demand” HIV prevention method was found to be ...
FEBRUARY 22, 2023
